Trimethoprim and fasting plasma homocysteine

Lancet

Volumn 352, Issue 9143, 1998, Pages 1827-1828

  Smulders, Yvo M ^a   De Man, Angelique M E ^b   Stehouwer, Coen D A ^b   Slaats, Ed H ^b  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ENZYME; COTRIMOXAZOLE; DIHYDROFOLATE REDUCTASE; FOLIC ACID; HOMOCYSTEINE; METHOTREXATE; TRIMETHOPRIM;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME INHIBITION; FOLIC ACID BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYPERHOMOCYSTEINEMIA; MALE; MEGALOBLASTIC ANEMIA; NAUSEA; NORMAL HUMAN; PANCYTOPENIA; PRIORITY JOURNAL; THROMBOSIS;

EID: 0032488377     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)79890-1     Document Type: Article

References (5)

1. 1 Lambie DG, Johnson RH. Drugs and folate metabolism. Drugs 1985; 30: 145-55.
2. 2 Chan MK, Beale D. Acute megaloblastosis due to co-trimoxazole. Br J Clin Pract 1980; 34: 187-88.
3. 3 Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270: 2693-98.
4. 4 Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338: 1042-50.
5. 5 Refsum H, Ueland PM, Kvinnsland S. Acute and long-term effects of high-dose methotrexate treatment on homocysteine in plasma and urine. Cancer Res 1986; 46: 5385-91.